Medical professionals from MicroVention, an American neuroendovascular medical device company, developed a new form of a stent with the potential to improve treatment for neurovascular disorders. In order to gain entry into the French market, Microvention contracted PHE to assist them in constructing a dossier to submit to the National Commission for Medical Devices.

After gathering evidence comparing the effectiveness of the new device to that of others on the market and analyzing data from countries that have already implemented the use of this device into their respective healthcare systems, we were able to create a dossier, giving Microvention the means to receive approval for reimbursement and to negotiate a market price.